NEW YORK and LEAMINGTON, Ontario — Tilray Brands Inc. submitted an application requesting an extension to regain compliance with Nasdaq’s listing standards regarding its price per share. The Company is evaluating several options including, but not limited to, a stockholder-approved Reverse Stock Split to address capital structure and maintain adherence to Nasdaq’s continued listing requirements.
Irwin Simon, Chief Executive Officer, Tilray Brands, stated, “Tilray’s trading levels have appreciated in recent weeks following President Trump’s review of cannabis rescheduling. We believe this market reaction reflects investors’ confidence in Tilray’s diversified global platform and our ability to capitalize on a more favorable regulatory environment. Tilray is a leader in cannabis, beverage, and wellness, and our growth potential extends beyond any single regulatory change. We are pleased to see investors more accurately recognizing the intrinsic value of our differentiated business portfolio. Tilray has multiple options to meet Nasdaq’s requirements, and with this extension request, we are giving the market additional time to demonstrate its confidence in our long-term strategy. We are building the future of consumer goods at Tilray, creating value for our customers, patients, and shareholders through a commitment to innovation at global scale.”
About Tilray Brands
Tilray Brands Inc. (Nasdaq: TLRY; TSX: TLRY), is a leading global lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America. Tilray’s mission is to be a leading premium lifestyle company with a house of brands and innovative products that inspire joy and create memorable experiences. Tilray’s platform supports over 40 brands in over 20 countries, including comprehensive cannabis offerings, hemp-based foods, and craft beverages.
Related Articles:
